Objectives-We hypothesized that arterial stiffness is associated with changes in the arterial protein profile, particularly of extracellular matrix components. We aimed at determining differentially expressed proteins by quantitative proteome analysis in arterial tissue from patients with different degrees of arterial stiffness. Approach and Results-Arterial stiffness, assessed by carotid-femoral pulse wave velocity (PWV), central blood pressure and augmentation index by pulse wave analysis were measured the day before surgery in a group of patients undergoing coronary artery bypass grafting. Protein extracts of well-defined, homogenous, nonatherosclerotic individual samples of the left mammary artery from 10 of these patients with high PWV and 9 with low PWV were compared by quantitative proteome analysis, using tandem mass tag labeling and nano-liquid chromatography mass spectrometry/mass spectrometry. Of 418 quantified proteins, 28 were differentially expressed between the groups with high and low PWV (P<0.05). Three of 7 members of the extracellular matrix family of small leucine-rich repeat proteoglycans displayed significant differences between the 2 groups (P=0.0079; Fisher exact test). Three other ECM proteins were differentially regulated, that is, collagen, type VIII, α-1 and α-2 and collagen, type IV, α-1. Several proteins related to smooth muscle cell function and structure were also found in different amounts between the 2 groups. Conclusions-Changes in the arterial amounts of small leucine-rich proteoglycans, known to be involved in collagen fibrillogenesis, and of some nonfibrillar collagens in combination with alterations in proteins related to functions of the human arterial smooth muscle are associated with arterial stiffness, as determined by PWV. (Arterioscler Thromb Vasc The online-only Data Supplement is available with this article at http://atvb.ahajournals.org/lookup/suppl/
A rterial stiffness is an independent predictor of cardiovascular risk. [1] [2] [3] Measures of aortic stiffness can be obtained in several ways, but the gold standard method is by carotidfemoral pulse wave velocity (PWV). PWV is estimated by dividing travelled distance of the pulse wave by transit time between the feet of 2 waveforms and is usually obtained transcutaneously at the site of the common carotid artery and the femoral artery. It is therefore an indirect measure of the changes in the biomechanical and hemodynamic properties of an arterial segment. The biomechanical properties of the arterial wall are determined by the composition of the extracellular matrix (ECM), notably by collagen abundance, the functional state of cells in the tissue and by the state of the connections between these different components in the form of cell-matrix and cell-cell interactions. 4 It is generally thought that the biological background behind changes in arterial stiffness, as for example with increasing age, is related to ECM remodeling. This remodeling is thought to consist mainly of increased collagen content and cross-linking, as well as of increased elastin degradation and fragmentation. [5] [6] [7] However, information concerning the precise molecular determinants of arterial stiffness is scant.
The arterial wall is primarily made up of vascular smooth muscle cells (VSMC) embedded in a dense ECM, consisting of elastin, collagens, glycoproteins, and proteoglycans. The group of matrix proteoglycans can be divided into large types (versican and aggrecan) and in small leucine-rich proteoglycans (SLRPs), which currently includes 14 different human types. These are divided into 4 classes based on amino acid sequence identity. SLRPs are known regulators of collagen fibril organization and fibrillogenesis. 8 Mice knockout models for SLRPs display disorganized collagen fibril network and loses functions of the connective tissue and present with different disorders related to abnormal collagen fibril sizes and network, such as aortic dissection and rupture, skin fragility, joint laxity, and tendon weakness. 9, 10 In this study, we hypothesized that patients with a high degree of arterial stiffness display a specific protein expression pattern different from patients with a normal low degree of arterial stiffness. We applied a quantitative proteomic approach to identify differentially expressed proteins in individual arterial tissue samples obtained from patients with high and low PWV. We investigate the internal mammary artery because this vessel has proven to be a suitable model artery for studies of generalized nonatherosclerotic arterial changes, that is, its matrix composition, endothelial function, and biochemistry reflect alterations in both the coronary and carotid arteries, as well as other features related to the arterial system. [11] [12] [13] 
Methods
Materials and Methods are available in the online-only Data Supplement.
Results
Baseline patient characteristics are summarized in Table 1 . There were no statistical differences in clinical parameters, comorbidities, or medical treatment between groups. Histological examinations of the arteries showed very homogenous samples, consisting mostly of tunica media with no atherosclerotic plaques present.
Mean PWV in the group of patients with a low degree of arterial stiffness was 8.8 m/s±0.37 (mean±SEM), and in patients with a high degree of arterial stiffness, PWV was 13.3 m/s±0.72 (mean±SEM). In the proteome analysis, we confidently quantified a total of 418 distinct proteins ( Table I in the online-only Data Supplement), whereof 28 proteins were differentially expressed between the 2 groups, when a cutoff of P<0.05 calculated by Student t test was used without correction for multiple testing. Among these proteins, 15 were shown to be significantly upregulated, whereas 13 proteins were downregulated in the high-PWV group, when compared with the group with normal PWV ( Table 2) .
Using the Panther molecular classification tool (Table 2) , 14 we found 6 ECM-related proteins. In our proteome analysis, we were able to quantitate 38 ECM molecules, as shown in Table 3 (9 proteoglycans, 17 collagens, and 12 glycoproteins). The 6 regulated matrix molecules included the downregulated proteins mimecan, asporin, and prolargin, which are all members of the family of SLRPs (Figure; Tables 2 and 3 ). To calculate the probability that this observation is by chance, we used Fisher exact test. When proteins with the t testcalculated P value of <0.05 were considered, 3 of 7 SLRPs were regulated, whereas 25 were differentially expressed out of 411 in the non-SLRP protein group (P=0.0079). When proteins with the t test-calculated P value of <0.10 were considered, 5 of 7 SLRPs were regulated, whereas 53 were differentially expressed out of 411 in the non-SLRP protein group (P=0.0007). In addition to regulations of members in the SLRP group, we also observed that collagen, type IV, α-1 and both α-chains (1 and 2) of collagen type VIII were upregulated among individuals with high PWV (Tables 2 and 3) , whereas no changes were seen in neither the abundant fibrillary collagens or in the group of matrix glycoproteins.
In addition to alterations in matrix molecules, we also identified several significantly regulated proteins related to regulation of smooth muscle cell functions and organization of the actin cytoskeleton. These included tubulin β-2A, tropomyosin α-4, WD repeat-containing protein 1, α-actinin 4, filamin A and filamin B, protein S100-A6, cysteine-rich protein 1, spectrin α-chain, PDZ, and LIM domain protein 3, septin-9, and lipoma-preferred partner ( Table 2 ).
The predictive value at an individual protein level was determined by using a logistic regressions model with high PWV as outcome ( Table 4 ). Several of the proteins as presented in Table 4 -and especially the ones related to the actin cytoskeleton-possessed abilities in predicting the outcome. For some of the proteins, the association was lost when we adjusted for mean blood pressure, whereas, in others, the predictive power increased after adjustment as can be seen in Table 4 . Measuring the mean blood pressure on its own did not predict PWV.
Discussion
In this study, we hypothesized that patients with a high degree of arterial stiffness display a specific arterial protein expression profile. We expected that differences in protein expression would include at least some ECM components because they are the primary structural components behind biomechanical properties of the arterial wall and of large artery stiffness. [5] [6] [7] We used the internal mammary artery from by-pass operations as a model artery to study the protein composition, although this artery does not contribute by itself to the calculated stiffness as estimated in the present investigation. However, both the matrix content and some biomechanical parameters of the internal mammary artery correlate well with values obtained in both the carotid and coronary arteries. [11] [12] [13] Using a quantitative proteomic approach, we confidently identified and quantified 418 proteins in arterial samples from 10 patients with high PWV and 9 patients with normal low PWV, whereof 28 proteins were differentially expressed. Most ECM proteins did not differ in the expression level between the 2 patient groups. However, the subgroup of matrix molecules, called SLRPs, was almost all significantly regulated. Our proteome analysis identified 7 proteins from this group, that is, decorin, biglycan, mimecan, lumican, prolargin, podocan, and asporin, which is in line with the fact that these proteins are abundantly expressed in many connective tissue types. 8 Of these proteins, mimecan, asporin, and prolargin were significantly downregulated in patients with high PWV and decorin and lumican showed trends toward downregulation with P values <0.1. The SLRPs are a family of ECM proteoglycans able to interact with collagens and thereby modify the deposition and arrangement of them. 8 On the basis of the association with the collagens, it is not surprising whether SLRPs are involved in regulation of biomechanical function of the arterial tissue and therefore associated with increased arterial stiffness. Mimecan, which we found downregulated in high PWV, is a proteoglycan mainly produced by smooth muscle cells and a regulator of collagen fibrillogenesis in the ECM. 15 Moreover, it modifies left ventricular hypertrophic response to hypertension. 16 Downregulation of mimecan is involved in aortic hypertrophy, adverse remodeling, and fibrosis in animal models with induced cardiac hypertrophy. 17 Asporin was also like fibromodulin downregulated in patients with high PWV, and both proteoglycans contribute to cardiac remodeling in an animal model of reperfusion. 18 In general, the SLRPs are working cooperatively and synergistic in the regulation of collagen fibrillogenesis and have the ability of altering expression in the absence of other members of the proteoglycan family. 19 Interestingly, a mouse model with knockout of biglycan presented with aortic dissection and rupture. 9 Studies of fibrillogenesis and ECM assembly in other tissues than vascular have suggested that decorin and lumican have regulatory abilities, 19 and in vitro studies indicate that dependent on SLRP expressions, collagen fibrils will be formed with either large or small diameters. 8 It is therefore tempting to speculate that the present observation concerning SLRPs may be associated with arterial stiffness through altered collagen fibril architecture. Also collagen cross-linkage, which is thought to contribute to arterial stiffness, 4-7 may be influenced by SLRPs. Furthermore, it is also of interest that the SLRPs may also regulate collagen turnover because several SLRPs bind and regulate the strong inducer of matrix formation, transforming growth factor-β, hereby possessing antifibrotic properties. 20, 21 In contrast to the observed regulation of the collagen fibrilassociated proteoglycans, none of the abundant fibrillar collagens (I, III, and V), 22 which all were present in our data set, were regulated.
In contrast to fibrillary collagens, 2 network-forming collagens, present in vascular basement membranes, were upregulated among the high-PWV group, that is, collagen type VIII (both α-1 and α-2 chains) and collagen type IV (α-1), and interestingly, the levels of these collagens were also significant predictors of PWV, when adjusting for blood pressure. Type VIII collagen is involved in VSMC migration, differentiation, and morphogenesis and is upregulated after vascular injury, [23] [24] [25] Collagen type VIII is moreover related to arterial stiffness in an animal model, 26 and polymorphisms in the COL8A1 gene are associated with age-related macular degeneration, a condition known to correlate with measures of arterial stiffness. [27] [28] [29] Collagen α-1 (IV) is abundantly present in the vascular wall, where it is the main component of basement membranes. 22 Its role in the vasculature is not well defined; however, it is interesting that a genome-wide association study of 4221 individuals found that a polymorphism in COL4A1 was highly significantly associated with PWV 30 and that an experimental study has found that mice with COL4A1 missense mutations display defects in several vascular functions and show low blood pressure. 31 It is moreover noteworthy that the arterial levels of these proteins are predictors of PWV, also when adjusting for blood pressure. The collagens and SLRPs were oppositely regulated as the SLRPs were downregulated and the collagens were upregulated in patients with a high degree of arterial stiffness. There are reports of opposite regulation of some SLRPs and collagens, involving interdependent effects through transforming growth factor-β 32 ; however, the exact nature of this observation remains to be investigated.
Several of the other regulated proteins were categorized as related to the actin cytoskeletal components. The actin skeleton acts as a connection between the contractile unit of the VSMCs and the ECM as multiprotein structures will bind to the actin cytoskeleton inside the cell and to the ECM through transmembrane proteins. 33 Lipoma preferred partner (LPP) was one of the proteins most significantly upregulated with high PWV identified in our study. LPP is an actin cytoskeleton protein that is highly expressed in VSMCs, 33 and an upregulation of this protein is related to smooth muscle cell migration. 34, 35 LPP is not only expressed in medial smooth muscle cells but also in the neointima after vascular injury, which supports its linkage to VSMC migration and vascular damage. 35 In the logistic regression, LPP was a predictor for PWV, but this association was lost when adjusting for mean blood pressure, indicating that the relationship between LPP and PWV is mainly caused by putative relations to the blood pressure. Filamin A and filamin B were both significantly regulated, although oppositely. Although filamin A is well described in the literature, not much information is available on filamin B. Filamin A has in experimental models proven to be one of the most efficient actin cross-linking proteins. 36 In other cell models, reduction in levels of filamin A decreases cell stiffness and seems to be of particular interest in regard of cell stiffness in relation to collagen. 37 Tropomyosin α-4 is an actin-binding protein, which was a significant predictor of PWV, also when adjusting for blood pressure. Tubulin β-2A was the most significantly regulated protein in our study.
Although not much information is available on this protein in relation to cardiovascular diseases, it has been found to be upregulated in surviving myocardial tissue after acute myocardial infraction. 38 Our results may be interesting in relation to the search for biochemical markers of arterial stiffness; however, we have not been able to find other studies concerning this matter or other indications that some of the identified proteins are relevant as biomarkers, but future studies will continue working on this issue.
Our study has several limitations. First, the number of available samples for quantitative proteome analysis is limited, excluding the possibility to do statistical analysis with corrections for multiple testing. Nevertheless, we were able to obtain lege artis significant changes when investigating regulation in the molecular subgroup of SLRPs. It is also important to mention that the quantitative protein results are dependent of efficient protein extraction, which is difficult to obtain in arterial tissue with a high content of matrix molecules. Thus, we cannot exclude that important difference may be present in the nonextracted part of the matrix molecules. Thirdly, the internal mammary artery is a muscular artery without atherosclerosis, which gives us the opportunity to analyze well-defined, homogeneous tissue samples, from an artery, that show similarities with, for example, the carotid and coronary arteries, about accumulation of matrix components and endothelial functions 11, 12 but which may not display putative associations between elastin-related proteins and stiffness because it is mainly a muscular artery with only few elastic membranes. Furthermore, it is important to realize that we cannot extract information concerning causality from our case-control study. Also, the absolute differences in protein levels in each group are relatively small, and the biological significance is unknown. Another important limitation to our study is in relation to blood pressure, which may play an important role. A tendency toward higher blood pressure was seen in the group with high PWV, and although this was not significant and blood pressure alone was not a predictor of PWV in the logistic regression model, we cannot exclude that blood pressure can play a role for the observed differences.
In conclusion, patients with a high degree of arterial stiffness showed significant downregulations of the amounts of several members of the family of SLRPs, a group of proteins involved in collagen fibril formation. Moreover, 3 networkforming and basement membrane-associated nonfibrillar collagens, that is, collagen type VIII (α-1 and -2) and type IV (α-1) and other proteins related to VSM structure and functions, were altered as well.
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